SCHEMBL1036014

SCHEMBL1036014

CC(C)C[C@H](N)C(=O)NCC(=O)NCC(=O)O

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.47
LMNA P02545 1/20 0.47
MAPT P10636 1/20 0.47
PTGS2 P35354 1/20 0.47
TDP1 Q9NUW8 1/20 0.47
SLC7A5 Q01650 1/20 0.47
ECE1 P42892 1/20 0.42
MME P08473 1/20 0.41
ACE P12821 1/20 0.41
CPA1 P15085 1/20 0.41
ACE2 Q9BYF1 1/20 0.41
LARS1 Q9P2J5 1/20 0.41
ANPEP P15144 2/20 0.40
RNPEP Q9H4A4 2/20 0.40
DNPEP Q9ULA0 1/20 0.40
PTGS1 P23219 1/20 0.39
GSTK1 Q9Y2Q3 1/20 0.39
OPRD1 P41143 2/20 0.38
OPRM1 P35372 1/20 0.38
OPRK1 P41145 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11291916 1.00 ALDH1A1 (0.47) ALDH1A1LMNAMAPTPTGS2TDP1
SCHEMBL29006326 1.00 ALDH1A1 (0.47) ALDH1A1LMNAMAPTPTGS2TDP1
SCHEMBL11291910 1.00 ALDH1A1 (0.47) ALDH1A1LMNAMAPTPTGS2TDP1
SCHEMBL2322417 1.00 ALDH1A1 (0.47) ALDH1A1LMNAMAPTPTGS2TDP1
SCHEMBL6047667 0.93 SLC7A5 (0.54) ALDH1A1LMNAMAPTPTGS2TDP1
SCHEMBL620370 0.93 SLC7A5 (0.54) ALDH1A1LMNAMAPTPTGS2TDP1
SCHEMBL620369 0.93 SLC7A5 (0.54) ALDH1A1LMNAMAPTPTGS2TDP1
Water SCHEMBL25363515 0.91 SLC7A5 (0.52) ALDH1A1LMNAMAPTPTGS2TDP1
Hydrochloric Acid SCHEMBL25317177 0.91 SLC7A5 (0.52) ALDH1A1LMNAMAPTPTGS2TDP1
Hydrochloric Acid SCHEMBL25317171 0.91 SLC7A5 (0.52) ALDH1A1LMNAMAPTPTGS2TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 8945 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260049102-A1 A PRO-MOIETY FOR FORMING A PRODRUG SELECTIVELY CLEAVED BY PROSTATE-SPECIFIC ANTIGEN (PSA) UNIV SYDNEY (AU) 2026-02-19 US claimed
US-20260001947-A1 MULTISPECIFIC ANTIBODY AND PREPARATION METHOD AND USE THEREOF MABNOOAH LLC (US) 2026-01-01 US claimed
US-12415852-B2 Multispecific antibody and preparation method and use thereof MABNOOAH LLC (US) 2025-09-16 US claimed
EP-4573105-A1 A PRO-MOIETY FOR FORMING A PRODRUG SELECTIVELY CLEAVED BY PROSTATE-SPECIFIC ANTIGEN (PSA) The University of Sydney (AU) 2025-06-25 EP claimed
US-20250027938-A1 METABOLIC SIGNATURE FOR PREDICTION OF MUCOSAL INFLAMMATION AND MICROBIAL COMPOSITION IMPERIAL COLLEGE INNOVATIONS LIMITED (GB) 2025-01-23 US claimed
CN-118727156-A Universal monocrystalline silicon texturing additive, texturing solution containing same, preparation method and application thereof 浙江奥首材料科技有限公司 2024-10-01 CN claimed
EP-4430402-A1 METHODS OF SELECTING A PATIENT FOR TREATMENT OF A MAGE-A1 POSITIVE SOLID TUMOR, OF PREDICTING WHETHER A PATIENT BEING DIAGNOSED WITH MAGE-A1 POSITIVE SOLID TUMOR WILL BE RESPONSIVE TO TREATMENT OF THIS TUMOR AND OF TREATING A PATIENT BEING DIAGNOSED WITH SUCH A MAGE-A1 POSITIVE SOLID TUMOR AS WELL AS CORRESPONDING PHARMACEUTICAL COMPOSITIONS AND DIAGNOSTIC KITS T-Knife GmbH (DE) 2024-09-18 EP claimed
CN-118307633-A Antarctic krill ACE (angiotensin converting enzyme) inhibitory peptide LGGIF, YLGGAL, LGGLNQ and application thereof 中国水产科学研究院黄海水产研究所 2024-07-09 CN claimed
EP-4370919-A1 METABOLIC SIGNATURE FOR PREDICTION OF MUCOSAL INFLAMMATION AND MICROBIAL COMPOSITION Imperial College Innovations Limited (GB) 2024-05-22 EP claimed
WO-2024036358-A1 A PRO-MOIETY FOR FORMING A PRODRUG SELECTIVELY CLEAVED BY PROSTATE-SPECIFIC ANTIGEN (PSA) THE UNIVERSITY OF SYDNEY (AU) 2024-02-22 WO claimed
CN-113416258-B Multispecific antibody and preparation method and application thereof 北京免疫方舟医药科技有限公司 2023-08-29 CN claimed
WO-2023083864-A1 METHODS OF SELECTING A PATIENT FOR TREATMENT OF A MAGE-A1 POSITIVE SOLID TUMOR, OF PREDICTING WHETHER A PATIENT BEING DIAGNOSED WITH MAGE-A1 POSITIVE SOLID TUMOR WILL BE RESPONSIVE TO TREATMENT OF THIS TUMOR AND OF TREATING A PATIENT BEING DIAGNOSED WITH SUCH A MAGE-A1 POSITIVE SOLID TUMOR AS WELL AS CORRESPONDING PHARMACEUTICAL COMPOSITIONS AND DIAGNOSTIC KITS T-KNIFE GMBH (DE) 2023-05-19 WO claimed
WO-2023285832-A1 METABOLIC SIGNATURE FOR PREDICTION OF MUCOSAL INFLAMMATION AND MICROBIAL COMPOSITION IMPERIAL COLLEGE INNOVATIONS LIMITED (GB) 2023-01-19 WO claimed
EP-3505154-B1 COMPOSITION FOR IMPROVING THE SOLUBILITY OF POORLY SOLUBLE SUBSTANCES, USE THEREOF AND COMPLEX FORMULATION CONTAINING THEREOF IND TECH RES INST (TW) 2022-04-06 EP claimed
CN-110512198-A A kind of chemical bronze plating liquid, chemical plating copper film and preparation method thereof SUZHOU SKYCHEM LTD 2019-11-29 CN claimed
US-9498520-B2 Use of proteases for gluten intolerance AMANO ENZYME INC. (JP) 2016-11-22 US claimed
US-20150182607-A1 Use of Proteases for Gluten Intolerance AMANO ENZYME USA CO. LTD. 2015-07-02 US claimed
US-9011842-B2 Use of proteases for gluten intolerance AMANO ENZYME INC. (JP) 2015-04-21 US claimed
US-5582817-A ORGANOZINC COMPOUNDS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1996-12-10 US claimed
EP-0583479-A1 REMEDY FOR DERMATOPATHY AND METALLOTHIONEIN INDUCER OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1994-02-23 EP claimed